Older Adults at Risk for Real-World Impersonation Scams
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Sept. 27, 2023 -- A considerable proportion of older adults engage with a mimicked real-world imposter scam without skepticism, according to a study published online Sept. 22 in JAMA Network Open.
Lei Yu, Ph.D., from the Rush University Medical Center in Chicago, and colleagues explored the vulnerability of older adults to a U.S. government impersonation scam in a cross-sectional study conducted from October to December 2021. A total of 644 participants were exposed to deceptive materials through mailers, emails, and phone calls by a live agent and were classified based on the phone call data as no engagement, engagement, and conversion.
The researchers found that 441 (68.5 percent) participants did not engage, 97 (15.1 percent) engaged but raised skepticism about the legitimacy of outreach, and 106 (16.4 percent) converted (answered or called in without skepticism, or confirmed that they did not change their personal information, or provided the last four digits of their Social Security number). The highest cognition and financial literacy were reported for older adults who engaged but with skepticism, while the lowest scam awareness was reported for those in the conversion group. There were no differences noted in psychological and other behavioral measures by levels of engagement.
"The findings of this cross-sectional study provide powerful evidence that many more older adults than currently recognized, including many without cognitive impairment, actively engage with potentially fraudulent pitches and are at risk of victimization and the deleterious health and financial consequences that result," the authors write.
Several authors reported employment by the Financial Industry Regulatory Authority (FINRA) Investor Education Foundation, a wholly owned subsidiary of FINRA and not-for-profit regulator of all securities firms doing business in the United States, which funded a portion of the study.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted September 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Allergy-Related Psychological Distress Common
TUESDAY, July 2, 2024 -- Psychological distress related to food allergies (FA) is common globally, according to a study published online June 21 in Allergy. Rebecca C...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.